Recursion Pharmaceuticals, Inc.
$3.46
-0.70 (-16.71%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- -2.1%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Largest decline max drawdown, since Aug 2026
- -27.5%
Own RXRX?
See how RXRX contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.